News | Heart Failure | March 02, 2017

BioVentrix TransCatheter Ventricular Enhancement System for Heart Failure Gains Reimbursement in Germany

Device receives highest priority designation for full reimbursement and a supplemental payment

BioVentrix, Revivent TC Transcatheter Ventricular Enhancement System, reimbursement, Germany

March 2, 2017 — BioVentrix Inc. announced that InEk, the German Institute for the Hospital Remuneration System, has awarded NUB Status 1 for the Revivent TC TransCatheter Ventricular Enhancement System for heart failure (HF).

The NUB process supports introduction of new and innovative medical devices in Germany. It allows participating hospitals to receive full reimbursement and a supplemental payment for new technologies in the German reimbursement system. NUB Status 1 is the highest priority designation available, and was only assigned to a small minority of product submissions for 2017.

BioVentrix recently received CE mark certification for its closed-chest Revivent TC TransCatheter Ventricular Enhancement System for plication of scar tissue in post-myocardial infarction (MI), ischemic cardiomyopathy patients. Placement of the Revivent TC System via the LIVE procedure obviates the need for more invasive surgery. Instead, small titanium anchors are placed along the outer surface of the heart and along one of the interior walls via a catheter-based approach. The anchors are then pulled towards one another, effectively excluding the scarred and non-functioning heart wall. Ventricular volume is immediately reduced as a result of the exclusion, by as much as 30-40 percent.

For more information: www.bioventrix.com


Additional Content

News | Cath Lab

Nov. 2, 2026 — Royal Philips has announced U.S. commercial availability of the HyperVue Integrated System1, a new single ...

Home November 03, 2026
Home
News | Cath Lab

Aug. 28, 2026 — Heartflow, Inc. has announced late-breaking one-year results from an independent randomized clinical ...

Home August 28, 2026
Home
News | Cath Lab

July 9, 2026 — On July 9, Stereotaxis announced that it has completed its previously announced acquisition of Robocath ...

Home July 10, 2026
Home
News | Cath Lab

June 18, 2026 — Allegheny Health Network's (AHN) Allegheny General Hospital (AGH) has completed a $19 million renovation ...

Home June 18, 2026
Home
News | Cath Lab

May 28, 2026 — RWJBarnabas Health has earned Cardiac Catheterization Lab Accreditation from the American College of ...

Home May 29, 2026
Home
Subscribe Now